Name (Synonyms) | Correlation | |
---|---|---|
drug1268 | anti-SARS-CoV-2 convalescent plasma Wiki | 0.50 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The purpose of this study is to determine whether XPro1595 can prevent the progression of respiratory complications in COVID19 patients.
Description: Treatment failure is defined by progression to one of the following: Transfer to ICU Need for mechanical New onset myocardial infarction or congestive heart failure Requirement for renal replacement therapy New onset of neurologic symptoms New onset of thrombotic or embolic event Death
Measure: Proportion of participants with treatment failure Time: 28 days